Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 4.750% 2/1
-
Market price (% of par)
-
68.86%
-
Total 13F principal
-
$92,980,000
-
Principal change
-
+$82,980,000
-
Total reported market value
-
$64,189,000
-
Number of holders
-
15
-
Value change
-
+$57,028,000
-
Number of buys
-
14
Institutional Holders of IMMUNOMEDICS INC - NOTE 4.750% 2/1 as of Q1 2016
As of 31 Mar 2016,
IMMUNOMEDICS INC - NOTE 4.750% 2/1 was held by
15 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$92,980,000
in principal (par value) of the bond.
The largest 10 bondholders included
ORBIMED ADVISORS LLC, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, BlueCrest Capital Management Ltd, AMERIPRISE FINANCIAL INC, Castle Creek Arbitrage, LLC, DEUTSCHE BANK AG\, Tekla Capital Management LLC, CSS LLC/IL, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
15
institutional bondholders reporting positions
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.